nodes	percent_of_prediction	percent_of_DWPC	metapath
Salmeterol—CYP3A7—Temsirolimus—kidney cancer	0.0876	0.112	CbGbCtD
Salmeterol—CYP3A7-CYP3A51P—Temsirolimus—kidney cancer	0.0876	0.112	CbGbCtD
Salmeterol—CYP3A5—Temsirolimus—kidney cancer	0.0657	0.0843	CbGbCtD
Salmeterol—CYP3A4—Everolimus—kidney cancer	0.0379	0.0487	CbGbCtD
Salmeterol—CYP2C8—Pazopanib—kidney cancer	0.0332	0.0426	CbGbCtD
Salmeterol—CYP3A7—Paclitaxel—kidney cancer	0.03	0.0386	CbGbCtD
Salmeterol—CYP3A7-CYP3A51P—Paclitaxel—kidney cancer	0.03	0.0386	CbGbCtD
Salmeterol—CYP3A7—Sorafenib—kidney cancer	0.0267	0.0342	CbGbCtD
Salmeterol—CYP3A7-CYP3A51P—Sorafenib—kidney cancer	0.0267	0.0342	CbGbCtD
Salmeterol—CYP3A7—Vincristine—kidney cancer	0.0259	0.0332	CbGbCtD
Salmeterol—CYP3A7-CYP3A51P—Vincristine—kidney cancer	0.0259	0.0332	CbGbCtD
Salmeterol—CYP3A4—Temsirolimus—kidney cancer	0.0256	0.0329	CbGbCtD
Salmeterol—CYP3A5—Erlotinib—kidney cancer	0.0246	0.0316	CbGbCtD
Salmeterol—CYP2C8—Erlotinib—kidney cancer	0.0237	0.0304	CbGbCtD
Salmeterol—CYP3A5—Paclitaxel—kidney cancer	0.0225	0.0289	CbGbCtD
Salmeterol—CYP2C8—Paclitaxel—kidney cancer	0.0217	0.0278	CbGbCtD
Salmeterol—CYP3A7-CYP3A51P—Sunitinib—kidney cancer	0.0216	0.0277	CbGbCtD
Salmeterol—CYP3A7—Sunitinib—kidney cancer	0.0216	0.0277	CbGbCtD
Salmeterol—CYP3A5—Sorafenib—kidney cancer	0.02	0.0257	CbGbCtD
Salmeterol—CYP3A5—Vincristine—kidney cancer	0.0194	0.0249	CbGbCtD
Salmeterol—CYP2C8—Sorafenib—kidney cancer	0.0192	0.0247	CbGbCtD
Salmeterol—CYP3A5—Sunitinib—kidney cancer	0.0162	0.0208	CbGbCtD
Salmeterol—CYP3A4—Pazopanib—kidney cancer	0.0135	0.0173	CbGbCtD
Salmeterol—CYP3A4—Erlotinib—kidney cancer	0.0096	0.0123	CbGbCtD
Salmeterol—CYP3A4—Paclitaxel—kidney cancer	0.00879	0.0113	CbGbCtD
Salmeterol—CYP3A4—Sorafenib—kidney cancer	0.00781	0.01	CbGbCtD
Salmeterol—CYP3A4—Vinblastine—kidney cancer	0.00771	0.00989	CbGbCtD
Salmeterol—CYP3A4—Vincristine—kidney cancer	0.00758	0.00972	CbGbCtD
Salmeterol—CYP3A4—Sunitinib—kidney cancer	0.00633	0.00812	CbGbCtD
Salmeterol—CYP3A4—Doxorubicin—kidney cancer	0.00474	0.00608	CbGbCtD
Salmeterol—Infection—Gemcitabine—kidney cancer	0.000168	0.000761	CcSEcCtD
Salmeterol—Back pain—Paclitaxel—kidney cancer	0.000168	0.00076	CcSEcCtD
Salmeterol—Dizziness—Vinblastine—kidney cancer	0.000167	0.000758	CcSEcCtD
Salmeterol—Dizziness—Everolimus—kidney cancer	0.000167	0.000756	CcSEcCtD
Salmeterol—Muscle spasms—Paclitaxel—kidney cancer	0.000167	0.000755	CcSEcCtD
Salmeterol—Abdominal pain—Sunitinib—kidney cancer	0.000166	0.000754	CcSEcCtD
Salmeterol—Body temperature increased—Sunitinib—kidney cancer	0.000166	0.000754	CcSEcCtD
Salmeterol—Diarrhoea—Erlotinib—kidney cancer	0.000166	0.000754	CcSEcCtD
Salmeterol—Nervous system disorder—Gemcitabine—kidney cancer	0.000166	0.000751	CcSEcCtD
Salmeterol—Feeling abnormal—Dactinomycin—kidney cancer	0.000164	0.000744	CcSEcCtD
Salmeterol—Skin disorder—Gemcitabine—kidney cancer	0.000164	0.000744	CcSEcCtD
Salmeterol—Rhinitis—Capecitabine—kidney cancer	0.000164	0.000742	CcSEcCtD
Salmeterol—Gastrointestinal pain—Dactinomycin—kidney cancer	0.000163	0.000739	CcSEcCtD
Salmeterol—Tremor—Paclitaxel—kidney cancer	0.000162	0.000736	CcSEcCtD
Salmeterol—Musculoskeletal discomfort—Vincristine—kidney cancer	0.000162	0.000735	CcSEcCtD
Salmeterol—Pharyngitis—Capecitabine—kidney cancer	0.000162	0.000735	CcSEcCtD
Salmeterol—Hypersensitivity—Sorafenib—kidney cancer	0.000161	0.000731	CcSEcCtD
Salmeterol—Insomnia—Vincristine—kidney cancer	0.000161	0.00073	CcSEcCtD
Salmeterol—Vomiting—Vinblastine—kidney cancer	0.000161	0.000729	CcSEcCtD
Salmeterol—Dizziness—Erlotinib—kidney cancer	0.000161	0.000729	CcSEcCtD
Salmeterol—Ill-defined disorder—Paclitaxel—kidney cancer	0.000161	0.000729	CcSEcCtD
Salmeterol—Connective tissue disorder—Capecitabine—kidney cancer	0.000161	0.000728	CcSEcCtD
Salmeterol—Vomiting—Everolimus—kidney cancer	0.00016	0.000726	CcSEcCtD
Salmeterol—Paraesthesia—Vincristine—kidney cancer	0.00016	0.000725	CcSEcCtD
Salmeterol—Agitation—Paclitaxel—kidney cancer	0.000159	0.000722	CcSEcCtD
Salmeterol—Rash—Everolimus—kidney cancer	0.000159	0.00072	CcSEcCtD
Salmeterol—Dermatitis—Everolimus—kidney cancer	0.000159	0.00072	CcSEcCtD
Salmeterol—Headache—Vinblastine—kidney cancer	0.000159	0.000719	CcSEcCtD
Salmeterol—Angioedema—Paclitaxel—kidney cancer	0.000158	0.000718	CcSEcCtD
Salmeterol—Headache—Everolimus—kidney cancer	0.000158	0.000716	CcSEcCtD
Salmeterol—Abdominal pain—Dactinomycin—kidney cancer	0.000158	0.000714	CcSEcCtD
Salmeterol—Body temperature increased—Dactinomycin—kidney cancer	0.000158	0.000714	CcSEcCtD
Salmeterol—Asthenia—Sorafenib—kidney cancer	0.000157	0.000712	CcSEcCtD
Salmeterol—Malaise—Paclitaxel—kidney cancer	0.000156	0.000708	CcSEcCtD
Salmeterol—Hypersensitivity—Sunitinib—kidney cancer	0.000155	0.000703	CcSEcCtD
Salmeterol—Vomiting—Erlotinib—kidney cancer	0.000155	0.000701	CcSEcCtD
Salmeterol—Musculoskeletal discomfort—Gemcitabine—kidney cancer	0.000154	0.000698	CcSEcCtD
Salmeterol—Fatigue—Vincristine—kidney cancer	0.000154	0.000696	CcSEcCtD
Salmeterol—Rash—Erlotinib—kidney cancer	0.000153	0.000695	CcSEcCtD
Salmeterol—Dermatitis—Erlotinib—kidney cancer	0.000153	0.000694	CcSEcCtD
Salmeterol—Palpitations—Paclitaxel—kidney cancer	0.000153	0.000694	CcSEcCtD
Salmeterol—Insomnia—Gemcitabine—kidney cancer	0.000153	0.000693	CcSEcCtD
Salmeterol—Headache—Erlotinib—kidney cancer	0.000152	0.000691	CcSEcCtD
Salmeterol—Pain—Vincristine—kidney cancer	0.000152	0.00069	CcSEcCtD
Salmeterol—Constipation—Vincristine—kidney cancer	0.000152	0.00069	CcSEcCtD
Salmeterol—Pain in extremity—Doxorubicin—kidney cancer	0.000152	0.00069	CcSEcCtD
Salmeterol—Paraesthesia—Gemcitabine—kidney cancer	0.000152	0.000688	CcSEcCtD
Salmeterol—Cardiac disorder—Capecitabine—kidney cancer	0.000152	0.000687	CcSEcCtD
Salmeterol—Cough—Paclitaxel—kidney cancer	0.000151	0.000685	CcSEcCtD
Salmeterol—Asthenia—Sunitinib—kidney cancer	0.000151	0.000685	CcSEcCtD
Salmeterol—Dyspnoea—Gemcitabine—kidney cancer	0.000151	0.000683	CcSEcCtD
Salmeterol—Nausea—Vinblastine—kidney cancer	0.00015	0.000681	CcSEcCtD
Salmeterol—Migraine—Doxorubicin—kidney cancer	0.00015	0.000679	CcSEcCtD
Salmeterol—Nausea—Everolimus—kidney cancer	0.00015	0.000679	CcSEcCtD
Salmeterol—Diarrhoea—Sorafenib—kidney cancer	0.00015	0.000679	CcSEcCtD
Salmeterol—Hypertension—Paclitaxel—kidney cancer	0.00015	0.000678	CcSEcCtD
Salmeterol—Immune system disorder—Capecitabine—kidney cancer	0.000148	0.000669	CcSEcCtD
Salmeterol—Chest pain—Paclitaxel—kidney cancer	0.000148	0.000669	CcSEcCtD
Salmeterol—Arthralgia—Paclitaxel—kidney cancer	0.000148	0.000669	CcSEcCtD
Salmeterol—Myalgia—Paclitaxel—kidney cancer	0.000148	0.000669	CcSEcCtD
Salmeterol—Mediastinal disorder—Capecitabine—kidney cancer	0.000147	0.000667	CcSEcCtD
Salmeterol—Anxiety—Paclitaxel—kidney cancer	0.000147	0.000666	CcSEcCtD
Salmeterol—Hypersensitivity—Dactinomycin—kidney cancer	0.000147	0.000666	CcSEcCtD
Salmeterol—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—kidney cancer	0.000147	0.000664	CcSEcCtD
Salmeterol—Arrhythmia—Capecitabine—kidney cancer	0.000146	0.000662	CcSEcCtD
Salmeterol—Discomfort—Paclitaxel—kidney cancer	0.000146	0.000661	CcSEcCtD
Salmeterol—Fatigue—Gemcitabine—kidney cancer	0.000146	0.00066	CcSEcCtD
Salmeterol—Gastrointestinal pain—Vincristine—kidney cancer	0.000146	0.00066	CcSEcCtD
Salmeterol—Dizziness—Sorafenib—kidney cancer	0.000145	0.000656	CcSEcCtD
Salmeterol—Constipation—Gemcitabine—kidney cancer	0.000144	0.000655	CcSEcCtD
Salmeterol—Pain—Gemcitabine—kidney cancer	0.000144	0.000655	CcSEcCtD
Salmeterol—Nausea—Erlotinib—kidney cancer	0.000144	0.000655	CcSEcCtD
Salmeterol—Dry mouth—Paclitaxel—kidney cancer	0.000144	0.000654	CcSEcCtD
Salmeterol—Diarrhoea—Sunitinib—kidney cancer	0.000144	0.000653	CcSEcCtD
Salmeterol—Mental disorder—Capecitabine—kidney cancer	0.000143	0.000649	CcSEcCtD
Salmeterol—Asthenia—Dactinomycin—kidney cancer	0.000143	0.000648	CcSEcCtD
Salmeterol—Malnutrition—Capecitabine—kidney cancer	0.000142	0.000645	CcSEcCtD
Salmeterol—Anaphylactic shock—Paclitaxel—kidney cancer	0.000141	0.000641	CcSEcCtD
Salmeterol—Oedema—Paclitaxel—kidney cancer	0.000141	0.000641	CcSEcCtD
Salmeterol—Abdominal pain—Vincristine—kidney cancer	0.000141	0.000638	CcSEcCtD
Salmeterol—Body temperature increased—Vincristine—kidney cancer	0.000141	0.000638	CcSEcCtD
Salmeterol—Infection—Paclitaxel—kidney cancer	0.000141	0.000637	CcSEcCtD
Salmeterol—Dizziness—Sunitinib—kidney cancer	0.000139	0.000631	CcSEcCtD
Salmeterol—Feeling abnormal—Gemcitabine—kidney cancer	0.000139	0.000631	CcSEcCtD
Salmeterol—Vomiting—Sorafenib—kidney cancer	0.000139	0.000631	CcSEcCtD
Salmeterol—Abdominal pain upper—Doxorubicin—kidney cancer	0.000139	0.00063	CcSEcCtD
Salmeterol—Nervous system disorder—Paclitaxel—kidney cancer	0.000139	0.000629	CcSEcCtD
Salmeterol—Tachycardia—Paclitaxel—kidney cancer	0.000138	0.000626	CcSEcCtD
Salmeterol—Rash—Sorafenib—kidney cancer	0.000138	0.000625	CcSEcCtD
Salmeterol—Dermatitis—Sorafenib—kidney cancer	0.000138	0.000625	CcSEcCtD
Salmeterol—Back pain—Capecitabine—kidney cancer	0.000138	0.000624	CcSEcCtD
Salmeterol—Skin disorder—Paclitaxel—kidney cancer	0.000137	0.000623	CcSEcCtD
Salmeterol—Headache—Sorafenib—kidney cancer	0.000137	0.000621	CcSEcCtD
Salmeterol—Muscle spasms—Capecitabine—kidney cancer	0.000137	0.00062	CcSEcCtD
Salmeterol—Diarrhoea—Dactinomycin—kidney cancer	0.000136	0.000618	CcSEcCtD
Salmeterol—Nasopharyngitis—Doxorubicin—kidney cancer	0.000136	0.000617	CcSEcCtD
Salmeterol—Vomiting—Sunitinib—kidney cancer	0.000134	0.000607	CcSEcCtD
Salmeterol—Body temperature increased—Gemcitabine—kidney cancer	0.000134	0.000605	CcSEcCtD
Salmeterol—Tremor—Capecitabine—kidney cancer	0.000133	0.000604	CcSEcCtD
Salmeterol—Rash—Sunitinib—kidney cancer	0.000133	0.000602	CcSEcCtD
Salmeterol—Dermatitis—Sunitinib—kidney cancer	0.000133	0.000601	CcSEcCtD
Salmeterol—Ill-defined disorder—Capecitabine—kidney cancer	0.000132	0.000598	CcSEcCtD
Salmeterol—Headache—Sunitinib—kidney cancer	0.000132	0.000598	CcSEcCtD
Salmeterol—Asthma—Doxorubicin—kidney cancer	0.000132	0.000596	CcSEcCtD
Salmeterol—Influenza—Doxorubicin—kidney cancer	0.000132	0.000596	CcSEcCtD
Salmeterol—Hypersensitivity—Vincristine—kidney cancer	0.000131	0.000595	CcSEcCtD
Salmeterol—Nausea—Sorafenib—kidney cancer	0.00013	0.000589	CcSEcCtD
Salmeterol—Musculoskeletal discomfort—Paclitaxel—kidney cancer	0.000129	0.000584	CcSEcCtD
Salmeterol—Malaise—Capecitabine—kidney cancer	0.000128	0.000581	CcSEcCtD
Salmeterol—Insomnia—Paclitaxel—kidney cancer	0.000128	0.00058	CcSEcCtD
Salmeterol—Asthenia—Vincristine—kidney cancer	0.000128	0.000579	CcSEcCtD
Salmeterol—Paraesthesia—Paclitaxel—kidney cancer	0.000127	0.000576	CcSEcCtD
Salmeterol—Vomiting—Dactinomycin—kidney cancer	0.000127	0.000574	CcSEcCtD
Salmeterol—Bronchitis—Doxorubicin—kidney cancer	0.000127	0.000574	CcSEcCtD
Salmeterol—Dyspnoea—Paclitaxel—kidney cancer	0.000126	0.000572	CcSEcCtD
Salmeterol—Palpitations—Capecitabine—kidney cancer	0.000126	0.00057	CcSEcCtD
Salmeterol—Rash—Dactinomycin—kidney cancer	0.000126	0.00057	CcSEcCtD
Salmeterol—Nausea—Sunitinib—kidney cancer	0.000125	0.000567	CcSEcCtD
Salmeterol—Dyspepsia—Paclitaxel—kidney cancer	0.000125	0.000564	CcSEcCtD
Salmeterol—Cough—Capecitabine—kidney cancer	0.000124	0.000563	CcSEcCtD
Salmeterol—Hypertension—Capecitabine—kidney cancer	0.000123	0.000557	CcSEcCtD
Salmeterol—Upper respiratory tract infection—Doxorubicin—kidney cancer	0.000122	0.000554	CcSEcCtD
Salmeterol—Fatigue—Paclitaxel—kidney cancer	0.000122	0.000553	CcSEcCtD
Salmeterol—Diarrhoea—Vincristine—kidney cancer	0.000122	0.000552	CcSEcCtD
Salmeterol—Asthenia—Gemcitabine—kidney cancer	0.000121	0.000549	CcSEcCtD
Salmeterol—Myalgia—Capecitabine—kidney cancer	0.000121	0.000549	CcSEcCtD
Salmeterol—Arthralgia—Capecitabine—kidney cancer	0.000121	0.000549	CcSEcCtD
Salmeterol—Chest pain—Capecitabine—kidney cancer	0.000121	0.000549	CcSEcCtD
Salmeterol—Pain—Paclitaxel—kidney cancer	0.000121	0.000548	CcSEcCtD
Salmeterol—Constipation—Paclitaxel—kidney cancer	0.000121	0.000548	CcSEcCtD
Salmeterol—Anxiety—Capecitabine—kidney cancer	0.000121	0.000547	CcSEcCtD
Salmeterol—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—kidney cancer	0.00012	0.000545	CcSEcCtD
Salmeterol—Discomfort—Capecitabine—kidney cancer	0.00012	0.000542	CcSEcCtD
Salmeterol—Hyperglycaemia—Doxorubicin—kidney cancer	0.000119	0.000538	CcSEcCtD
Salmeterol—Dry mouth—Capecitabine—kidney cancer	0.000118	0.000537	CcSEcCtD
Salmeterol—Nausea—Dactinomycin—kidney cancer	0.000118	0.000537	CcSEcCtD
Salmeterol—Pneumonia—Doxorubicin—kidney cancer	0.000118	0.000535	CcSEcCtD
Salmeterol—Dizziness—Vincristine—kidney cancer	0.000118	0.000534	CcSEcCtD
Salmeterol—Infestation NOS—Doxorubicin—kidney cancer	0.000117	0.000532	CcSEcCtD
Salmeterol—Infestation—Doxorubicin—kidney cancer	0.000117	0.000532	CcSEcCtD
Salmeterol—Feeling abnormal—Paclitaxel—kidney cancer	0.000117	0.000528	CcSEcCtD
Salmeterol—Oedema—Capecitabine—kidney cancer	0.000116	0.000526	CcSEcCtD
Salmeterol—Gastrointestinal pain—Paclitaxel—kidney cancer	0.000116	0.000524	CcSEcCtD
Salmeterol—Diarrhoea—Gemcitabine—kidney cancer	0.000116	0.000524	CcSEcCtD
Salmeterol—Infection—Capecitabine—kidney cancer	0.000115	0.000523	CcSEcCtD
Salmeterol—Urinary tract infection—Doxorubicin—kidney cancer	0.000114	0.000517	CcSEcCtD
Salmeterol—Conjunctivitis—Doxorubicin—kidney cancer	0.000114	0.000517	CcSEcCtD
Salmeterol—Nervous system disorder—Capecitabine—kidney cancer	0.000114	0.000516	CcSEcCtD
Salmeterol—Tachycardia—Capecitabine—kidney cancer	0.000113	0.000513	CcSEcCtD
Salmeterol—Vomiting—Vincristine—kidney cancer	0.000113	0.000513	CcSEcCtD
Salmeterol—Skin disorder—Capecitabine—kidney cancer	0.000113	0.000511	CcSEcCtD
Salmeterol—Urticaria—Paclitaxel—kidney cancer	0.000112	0.000509	CcSEcCtD
Salmeterol—Rash—Vincristine—kidney cancer	0.000112	0.000509	CcSEcCtD
Salmeterol—Dermatitis—Vincristine—kidney cancer	0.000112	0.000508	CcSEcCtD
Salmeterol—Body temperature increased—Paclitaxel—kidney cancer	0.000112	0.000507	CcSEcCtD
Salmeterol—Abdominal pain—Paclitaxel—kidney cancer	0.000112	0.000507	CcSEcCtD
Salmeterol—Headache—Vincristine—kidney cancer	0.000112	0.000506	CcSEcCtD
Salmeterol—Epistaxis—Doxorubicin—kidney cancer	0.000111	0.000502	CcSEcCtD
Salmeterol—Sinusitis—Doxorubicin—kidney cancer	0.00011	0.000499	CcSEcCtD
Salmeterol—Vomiting—Gemcitabine—kidney cancer	0.000107	0.000487	CcSEcCtD
Salmeterol—Rash—Gemcitabine—kidney cancer	0.000107	0.000483	CcSEcCtD
Salmeterol—Dermatitis—Gemcitabine—kidney cancer	0.000106	0.000482	CcSEcCtD
Salmeterol—Headache—Gemcitabine—kidney cancer	0.000106	0.00048	CcSEcCtD
Salmeterol—Nausea—Vincristine—kidney cancer	0.000106	0.000479	CcSEcCtD
Salmeterol—Musculoskeletal discomfort—Capecitabine—kidney cancer	0.000106	0.000479	CcSEcCtD
Salmeterol—Rhinitis—Doxorubicin—kidney cancer	0.000106	0.000479	CcSEcCtD
Salmeterol—Insomnia—Capecitabine—kidney cancer	0.000105	0.000476	CcSEcCtD
Salmeterol—Pharyngitis—Doxorubicin—kidney cancer	0.000105	0.000474	CcSEcCtD
Salmeterol—Paraesthesia—Capecitabine—kidney cancer	0.000104	0.000472	CcSEcCtD
Salmeterol—Hypersensitivity—Paclitaxel—kidney cancer	0.000104	0.000472	CcSEcCtD
Salmeterol—Connective tissue disorder—Doxorubicin—kidney cancer	0.000104	0.000469	CcSEcCtD
Salmeterol—Dyspnoea—Capecitabine—kidney cancer	0.000103	0.000469	CcSEcCtD
Salmeterol—Dyspepsia—Capecitabine—kidney cancer	0.000102	0.000463	CcSEcCtD
Salmeterol—Asthenia—Paclitaxel—kidney cancer	0.000101	0.00046	CcSEcCtD
Salmeterol—Nausea—Gemcitabine—kidney cancer	0.0001	0.000455	CcSEcCtD
Salmeterol—Fatigue—Capecitabine—kidney cancer	0.0001	0.000454	CcSEcCtD
Salmeterol—Pain—Capecitabine—kidney cancer	9.93e-05	0.00045	CcSEcCtD
Salmeterol—Constipation—Capecitabine—kidney cancer	9.93e-05	0.00045	CcSEcCtD
Salmeterol—Cardiac disorder—Doxorubicin—kidney cancer	9.78e-05	0.000443	CcSEcCtD
Salmeterol—Diarrhoea—Paclitaxel—kidney cancer	9.68e-05	0.000439	CcSEcCtD
Salmeterol—Feeling abnormal—Capecitabine—kidney cancer	9.57e-05	0.000434	CcSEcCtD
Salmeterol—Immune system disorder—Doxorubicin—kidney cancer	9.51e-05	0.000431	CcSEcCtD
Salmeterol—Gastrointestinal pain—Capecitabine—kidney cancer	9.49e-05	0.00043	CcSEcCtD
Salmeterol—Mediastinal disorder—Doxorubicin—kidney cancer	9.49e-05	0.00043	CcSEcCtD
Salmeterol—Arrhythmia—Doxorubicin—kidney cancer	9.41e-05	0.000426	CcSEcCtD
Salmeterol—Dizziness—Paclitaxel—kidney cancer	9.35e-05	0.000424	CcSEcCtD
Salmeterol—Mental disorder—Doxorubicin—kidney cancer	9.23e-05	0.000418	CcSEcCtD
Salmeterol—Urticaria—Capecitabine—kidney cancer	9.22e-05	0.000418	CcSEcCtD
Salmeterol—Abdominal pain—Capecitabine—kidney cancer	9.18e-05	0.000416	CcSEcCtD
Salmeterol—Body temperature increased—Capecitabine—kidney cancer	9.18e-05	0.000416	CcSEcCtD
Salmeterol—Malnutrition—Doxorubicin—kidney cancer	9.17e-05	0.000416	CcSEcCtD
Salmeterol—Tension—Doxorubicin—kidney cancer	9e-05	0.000408	CcSEcCtD
Salmeterol—Vomiting—Paclitaxel—kidney cancer	8.99e-05	0.000408	CcSEcCtD
Salmeterol—Rash—Paclitaxel—kidney cancer	8.92e-05	0.000404	CcSEcCtD
Salmeterol—Dermatitis—Paclitaxel—kidney cancer	8.91e-05	0.000404	CcSEcCtD
Salmeterol—Nervousness—Doxorubicin—kidney cancer	8.91e-05	0.000404	CcSEcCtD
Salmeterol—Back pain—Doxorubicin—kidney cancer	8.87e-05	0.000402	CcSEcCtD
Salmeterol—Headache—Paclitaxel—kidney cancer	8.86e-05	0.000402	CcSEcCtD
Salmeterol—Muscle spasms—Doxorubicin—kidney cancer	8.82e-05	0.0004	CcSEcCtD
Salmeterol—Hypersensitivity—Capecitabine—kidney cancer	8.55e-05	0.000388	CcSEcCtD
Salmeterol—Ill-defined disorder—Doxorubicin—kidney cancer	8.51e-05	0.000386	CcSEcCtD
Salmeterol—Agitation—Doxorubicin—kidney cancer	8.43e-05	0.000382	CcSEcCtD
Salmeterol—Nausea—Paclitaxel—kidney cancer	8.4e-05	0.000381	CcSEcCtD
Salmeterol—Asthenia—Capecitabine—kidney cancer	8.33e-05	0.000377	CcSEcCtD
Salmeterol—Malaise—Doxorubicin—kidney cancer	8.27e-05	0.000375	CcSEcCtD
Salmeterol—Palpitations—Doxorubicin—kidney cancer	8.1e-05	0.000367	CcSEcCtD
Salmeterol—Cough—Doxorubicin—kidney cancer	8e-05	0.000363	CcSEcCtD
Salmeterol—Diarrhoea—Capecitabine—kidney cancer	7.94e-05	0.00036	CcSEcCtD
Salmeterol—Hypertension—Doxorubicin—kidney cancer	7.92e-05	0.000359	CcSEcCtD
Salmeterol—Arthralgia—Doxorubicin—kidney cancer	7.81e-05	0.000354	CcSEcCtD
Salmeterol—Myalgia—Doxorubicin—kidney cancer	7.81e-05	0.000354	CcSEcCtD
Salmeterol—Chest pain—Doxorubicin—kidney cancer	7.81e-05	0.000354	CcSEcCtD
Salmeterol—Anxiety—Doxorubicin—kidney cancer	7.78e-05	0.000353	CcSEcCtD
Salmeterol—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—kidney cancer	7.75e-05	0.000351	CcSEcCtD
Salmeterol—Discomfort—Doxorubicin—kidney cancer	7.71e-05	0.00035	CcSEcCtD
Salmeterol—Dizziness—Capecitabine—kidney cancer	7.68e-05	0.000348	CcSEcCtD
Salmeterol—Dry mouth—Doxorubicin—kidney cancer	7.63e-05	0.000346	CcSEcCtD
Salmeterol—Anaphylactic shock—Doxorubicin—kidney cancer	7.48e-05	0.000339	CcSEcCtD
Salmeterol—Oedema—Doxorubicin—kidney cancer	7.48e-05	0.000339	CcSEcCtD
Salmeterol—Infection—Doxorubicin—kidney cancer	7.43e-05	0.000337	CcSEcCtD
Salmeterol—Vomiting—Capecitabine—kidney cancer	7.38e-05	0.000335	CcSEcCtD
Salmeterol—Nervous system disorder—Doxorubicin—kidney cancer	7.34e-05	0.000333	CcSEcCtD
Salmeterol—Rash—Capecitabine—kidney cancer	7.32e-05	0.000332	CcSEcCtD
Salmeterol—Dermatitis—Capecitabine—kidney cancer	7.31e-05	0.000331	CcSEcCtD
Salmeterol—Tachycardia—Doxorubicin—kidney cancer	7.3e-05	0.000331	CcSEcCtD
Salmeterol—Headache—Capecitabine—kidney cancer	7.27e-05	0.00033	CcSEcCtD
Salmeterol—Skin disorder—Doxorubicin—kidney cancer	7.27e-05	0.000329	CcSEcCtD
Salmeterol—Nausea—Capecitabine—kidney cancer	6.9e-05	0.000313	CcSEcCtD
Salmeterol—Musculoskeletal discomfort—Doxorubicin—kidney cancer	6.82e-05	0.000309	CcSEcCtD
Salmeterol—Insomnia—Doxorubicin—kidney cancer	6.77e-05	0.000307	CcSEcCtD
Salmeterol—Paraesthesia—Doxorubicin—kidney cancer	6.72e-05	0.000305	CcSEcCtD
Salmeterol—Dyspnoea—Doxorubicin—kidney cancer	6.67e-05	0.000302	CcSEcCtD
Salmeterol—Dyspepsia—Doxorubicin—kidney cancer	6.59e-05	0.000299	CcSEcCtD
Salmeterol—Fatigue—Doxorubicin—kidney cancer	6.45e-05	0.000292	CcSEcCtD
Salmeterol—Pain—Doxorubicin—kidney cancer	6.4e-05	0.00029	CcSEcCtD
Salmeterol—Constipation—Doxorubicin—kidney cancer	6.4e-05	0.00029	CcSEcCtD
Salmeterol—Feeling abnormal—Doxorubicin—kidney cancer	6.17e-05	0.000279	CcSEcCtD
Salmeterol—Gastrointestinal pain—Doxorubicin—kidney cancer	6.12e-05	0.000277	CcSEcCtD
Salmeterol—Urticaria—Doxorubicin—kidney cancer	5.94e-05	0.000269	CcSEcCtD
Salmeterol—Body temperature increased—Doxorubicin—kidney cancer	5.92e-05	0.000268	CcSEcCtD
Salmeterol—Abdominal pain—Doxorubicin—kidney cancer	5.92e-05	0.000268	CcSEcCtD
Salmeterol—Hypersensitivity—Doxorubicin—kidney cancer	5.51e-05	0.00025	CcSEcCtD
Salmeterol—Asthenia—Doxorubicin—kidney cancer	5.37e-05	0.000243	CcSEcCtD
Salmeterol—Diarrhoea—Doxorubicin—kidney cancer	5.12e-05	0.000232	CcSEcCtD
Salmeterol—Dizziness—Doxorubicin—kidney cancer	4.95e-05	0.000224	CcSEcCtD
Salmeterol—Vomiting—Doxorubicin—kidney cancer	4.76e-05	0.000216	CcSEcCtD
Salmeterol—Rash—Doxorubicin—kidney cancer	4.72e-05	0.000214	CcSEcCtD
Salmeterol—Dermatitis—Doxorubicin—kidney cancer	4.71e-05	0.000214	CcSEcCtD
Salmeterol—Headache—Doxorubicin—kidney cancer	4.69e-05	0.000212	CcSEcCtD
Salmeterol—Nausea—Doxorubicin—kidney cancer	4.44e-05	0.000201	CcSEcCtD
